The Oman Medical Consumables Market Research Report: Size, Share, Trends & Forecast (2026-2032)

The Oman Medical Consumables Market Report Key Takeaways:

• Market size was valued at around USD 78.75 Million in 2025 and is projected to reach USD 112.29 Million by 2032. The estimated CAGR from 2026 to 2032 is around 6.6%, indicating strong growth.
• By Division, the exam gloves segment represented a significant share of about 13% in the Oman Medical Consumables Market in 2025.
• By Material, the disposable segment presented a significant share of about 65% in the Oman Medical Consumables Market in 2025.
• Leading Medical Consumables Companies in the Oman Market are Muscat Pharmacy & Stores LLC, Al Zahrawi Medical Supplies LLC (Oman), Bahwan Healthcare Centre (BHC), Alfarsi Medical Supplies, Gulf Medical Supplies LLC, Oman Medical Supplies and Services Co. LLC (Oman Med), Waleed Pharmacy & Stores LLC, Salalah Medical Supplies MFG Co. LLC, Med Smart Medical & Dental Supplies, Intra Medica and Others.

Market Insights & Analysis: The Oman Medical Consumables Market (2026-32):

The Oman Medical Consumables Market size was valued at approximately USD 78.75 Million in 2025 and is projected to reach USD 112.29 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 6.6% during the forecast period, i.e., 2026-32.

Oman’s market is significantly growing due to the government’s sustained commitment to strengthening the healthcare system, with billions of dollars allocated to the sector. This substantial public expenditure signals a strategic focus on upgrading service delivery infrastructure and expanding capacity across healthcare institutions. Elevated fiscal support at the national level reinforces structured procurement cycles for medical supplies and sustains institutional demand for clinical consumables across hospitals, specialty centres, and primary care facilities. In April 2025, the Ministry of Health launched the National Health Policy, prioritising cross-sector collaboration and long-term health system sustainability to manage demographic transitions and non-communicable disease burdens.

Additionally, the consumption of medicine, surgical consumables & instruments in 2023 in Oman totalled approximately 129,339 thousand R.O., indicating a rising base level of clinical supplies usage. Institutional users, particularly public hospitals and health centres, constitute the end-user segment, with consumables supporting extensive clinical operations from routine diagnostics to surgical interventions. As per the World Health Organization, Oman’s population is above 5 million, with sustained life expectancy trends that underlie increased utilization of routine and specialty healthcare services.

Within this context, tertiary referral centres and outpatient departments generate consistent recurring demand for consumables that support both acute care and chronic disease management. Budgetary provisions for 3,706 additional healthcare personnel in 2026 are also expected to expand clinical throughput in diagnostic and treatment units, thereby elevating annual consumables turnover. Moreover, the national policy’s HiAP framework augments preventive care participation in primary care settings, strengthening the institutional demand footprint and broadening usage contexts beyond acute inpatient procedures.

Furthermore, the forward-looking prospects remain anchored in the Eleventh Five-Year Development Plan (2026–2030), which underlines broader expansion of social services as part of national socioeconomic transformation. Emerging investments in regional health hubs and ancillary health institutions are projected to improve access levels outside urban centres, promoting a geographically diversified demand base for consumables. The ongoing modernisation of healthcare delivery and the expansion of institutional capacity collectively signal a robust structural trajectory for consumable consumption, with sustained policy alignment fostering predictable and expanding market conditions.

The Oman Medical Consumables Market Scope:

The Oman Medical Consumables Market Driver:

Rising Chronic Disease Prevalence in Oman

The increasing prevalence of chronic diseases such as diabetes, hypertension, heart disease, and cancer is a structural driver enlarging demand for medical consumables in Oman. In early 2025, the Ministry of Health reported that non-communicable diseases (NCDs) account for approximately 80% of deaths in the country, imposing an economic burden due to prolonged treatment needs and long-term clinical care requirements.

Aligned with this, the national survey initiative launched in January 2025 aims to collect detailed prevalence data on NCDs, including cardiovascular illness and chronic respiratory disease, across multiple governorates, demonstrating government recognition of a growing disease burden that necessitates expanded healthcare interventions, thus increasing the market growth.

Additionally, the World Health Organization’s regional reporting indicates a marked rise in risk factors such as overweight and obesity among Oman’s population, contributing to the elevated incidence of chronic conditions that require regular monitoring, diagnostics, and therapeutic consumables over patients’ lifetimes.

Moreover, chronic disease prevalence drives structural demand because long-term management protocols rely on recurrent use of single-use clinical supplies such as syringes for insulin administration, vascular access devices for extended care, and diagnostic disposables for routine testing. The sustained nature of care for patients with chronic illnesses ensures that growth in disease prevalence translates into an enduring increase in consumables volume, not merely short-term adoption.

The Oman Medical Consumables Market Trend:

Premiumization of Advanced Wound Care Consumables

A structural shift toward high-performance wound care consumables is emerging as a defining trend in the Oman Medical Consumables Market. Healthcare institutions are progressively replacing conventional gauze-based materials with clinically differentiated, technology-integrated dressing solutions.

Hospitals and tertiary care centres are expanding procurement of antimicrobial silver and iodine-impregnated dressings, Hydro Fiber, foam, and alginate absorbent dressings, Silicone-border atraumatic wound covers, Collagen and bioactive wound matrices, and single-use negative pressure wound therapy (NPWT) dressing kits. These innovative solutions are actively transforming the market growth.

This transition reflects a broader move toward protocol-driven wound management frameworks, where product selection is standardized around performance outcomes rather than cost-minimization alone.

Additionally, hospitals are adopting pre-configured sterile wound care kits, disposable NPWT canisters, and infection-control embedded dressing systems to streamline clinical workflow and minimize contamination risks. Procurement specifications are increasingly Stock Keeping Unit (SKU)-specific, signalling a shift from generic supplies to differentiated consumable portfolios.

The trend is further reinforced by rising chronic wound incidence associated with diabetes and metabolic disorders, which necessitates prolonged dressing cycles and continuous consumable utilization. As chronic wound management pathways become institutionalized within referral hospitals, recurring demand for advanced single-use wound consumables is strengthening.

Overall, the premiumization and clinical differentiation of wound care products represent a sustained structural transformation in consumables utilization across Oman’s healthcare ecosystem, supporting long-term market value expansion.

The Oman Medical Consumables Market Opportunity:

Expansion of Specialty Healthcare Infrastructure and Medical Industrial Clusters

The market is rapidly emerging from the planned expansion of specialty healthcare infrastructure alongside the development of medical industrial clusters. Under Vision 2040, the government continues to prioritize tertiary care enhancement, including oncology, nephrology, and advanced surgical services across major governorates. Recent healthcare budget allocations exceeding USD 780 million reaffirm sustained capital investment in hospital upgrades and specialty treatment capacity . As new oncology units, dialysis centers, and referral hospitals become operational in phases beyond 2026, procedural intensity is expected to rise materially.

Additionally, specialty service expansion structurally elevates recurring demand for infusion sets, syringes, IV cannulas, dialysis consumables, and infection-control disposables. For instance, Oman’s SOHAR Freezone signed a land lease in 2025 for the development of a USD 20 million pharmaceutical and medical supplies manufacturing facility, which will include sterile production lines for medical gloves and sterile gauze. Scheduled to commence operations in 2027, the plant will strengthen domestic production capacity for essential consumables. Each incremental increase in installed treatment capacity, therefore, translates into sustained procurement cycles for high-volume consumable categories.

Concurrently, industrial zones such as Khazaen Economic City are promoting medical manufacturing through tax incentives, customs exemptions, and long-term land leases. This policy alignment creates an ecosystem where expanding healthcare demand can be supported by localized production of high-frequency disposable products. Emerging manufacturers and distributors can leverage early-stage vendor onboarding during new facility commissioning while benefiting from industrial incentives. Together, specialty healthcare expansion and medical industrial clustering establish a structurally scalable growth pathway within Oman’s Medical Consumables Market.

The Oman Medical Consumables Market Challenge:

High Import Dependence and Regulatory Compliance Burden

A critical structural challenge in this market is the continued reliance on imported disposable medical products combined with evolving regulatory requirements. Despite industrial localization initiatives, a substantial portion of sterile consumables such as syringes, IV sets, and wound-care products is sourced from international suppliers. Import dependence exposes distributors and healthcare providers to freight volatility, global supply chain disruptions, and currency fluctuations. These exter nal risks directly affect procurement planning, pricing stability, and inventory management across public and private hospitals.

Oman remains significantly reliant on imports to meet its medical consumables demand, as reflected in 2023 trade data from the World Integrated Trade Solution (WITS) based on UN Comtrade statistics. Imports of diagnostic reagents and medical test kits reached approximately USD 46.7 million in 2023, making it the largest consumables category. Syringe imports totalled around USD 3.04 million , indicating stable recurring procurement across healthcare facilities. Overall, Oman’s continued dependence on international sourcing for essential hospital and laboratory consumables.

Moreover, the regulatory framework governing medical products has also become more structured in recent years. Registration, quality certification, and conformity assessment procedures require documented compliance with safety and performance standards before market entry. While these measures strengthen patient safety and align with international best practices, they increase administrative timelines and upfront compliance costs for suppliers. Smaller distributors and new entrants often face longer approval cycles, which can delay product launches and restrict rapid portfolio expansion.

This dual pressure of import reliance and regulatory complexity materially constrains market scalability. Procurement entities prioritize pre-approved vendors with established documentation histories, limiting competitive access for emerging players. Additionally, compliance-related costs can reduce pricing flexibility in a market where public sector tenders remain cost-sensitive. Consequently, structural supply-chain exposure and regulatory procedural demands represent a measurable barrier to expansion within Oman’s medical consumables sector.

The Oman Medical Consumables Market (2026-32) Segmentation Analysis:

The Oman Medical Consumables Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2026–32 at the Oman level. Based on the analysis, the market has been further classified as;

Based on the Division

• Exam Gloves
• Surgeons’ Gloves
• Diagnostics Consumables
• O.R. Consumables (non-glove)
• Anaesthesia Consumables
• Advanced Wound Care
• Vascular Access
• Laboratory Consumables
• Respiratory Consumables
• EVS / Infection Control
• Personal Protection (non-glove PPE)
• Urology
• Personal Care
• Primary + Preventive Care
• SPT
• Ready Care
• Rehab & Fall Prevention
• Medline Textiles
• Others / Misc.

Exam Gloves are expected to maintain dominance in Oman’s Medical Consumables Market during 2026–2032 with a market share of 13%. Their leadership is structurally linked to universal usage across public hospitals, private clinics, laboratories, dialysis centres, and ambulatory facilities. Infection prevention protocols mandated by the Ministry of Health include scheduled glove use in high-risk patient contact and invasive procedures, as detailed in the 2025 national hand hygiene policy. The Ministry’s 2024 sterilization guideline further institutionalizes strict hygiene standards requiring routine use of sterile consumables. Moreover, public hospitals performed over 86,500 surgeries in 2023, indicating procedure volumes that inherently drive daily glove consumption.

The dominance of exam gloves is further supported by strict infection control frameworks across tertiary hospitals and regional health centres. Healthcare infrastructure investments exceeding USD 3.5 billion in recent state budgets have expanded treatment capacity, indirectly raising the consumption intensity of basic protective consumables . Unlike specialized consumables that depend on particular procedures, exam gloves are non-substitutable and required across all clinical departments. This universal applicability, combined with centralized public procurement systems, ensures sustained high-volume tender cycles .

Private healthcare growth and outpatient service expansion also reinforce segment leadership. Rapid patient turnover in ambulatory and diagnostic settings increases glove usage per operating hour. Furthermore, localized manufacturing initiatives in industrial zones such as Sohar Freezone are expected to stabilize supply and reduce import volatility. Collectively, regulatory compliance, infrastructure expansion, and universal end-user reliance position exam gloves as the structurally dominant division within Oman’s medical consumables market.

Based on Material

• Disposable
• Non-Disposable

The disposable segment remains the leading category within the Oman Medical Consumables Market, with a market share of 65% driven by sustained procedural volumes and infection control requirements. This leadership is directly linked to national infection prevention standards that prioritize single-use sterile products across surgical, dialysis, oncology, and critical care environments. Disposable consumables eliminate cross-contamination risks and reduce sterilization dependency, aligning with the Ministry of Health patient safety directives. As specialty services expand, the frequency of sterile, single-use product utilization rises proportionally.

Additionally, public hospital procurement policies strongly favour disposable items due to predictable infection control compliance and operational efficiency . High-frequency procedures such as chemotherapy administration, haemodialysis sessions, and minimally invasive surgeries require sterile, one-time-use syringes, IV sets, drapes, and catheters . The expansion of day-care and outpatient surgical models further amplifies disposable product intensity due to rapid patient turnover. Consequently, recurring purchasing cycles remain structurally tied to healthcare capacity growth.

Moreover, investment momentum within Oman’s healthcare manufacturing landscape is increasingly visible beyond traditional industrial hubs. For instance, in May 2025, expansion in the investment in Dhofar’s pharmaceutical industry, including facilities producing medical gloves, masks, cotton, and bandages. This development signals tangible progress in localizing the production of high-volume disposable healthcare materials. Therefore, infection control mandates, procedural expansion, and policy-aligned procurement frameworks collectively sustain the leadership of disposable medical consumables in Oman.

Oman Medical Consumables Market (2026-32) Regional Analysis:

Muscat Governorate is the primary driver of medical consumables demand within Oman due to its concentration of advanced healthcare infrastructure and the highest procedural volume in the country. Muscat’s major public hospitals, including Khoula and Al Nahda, alone performed over 25,000 surgeries in 2025, nearly doubling surgical activity compared to earlier years and signifying a strong center of clinical throughput that directly increases consumption of sterile disposable products such as gloves, syringes, IV sets, and drapes.

As the administrative and healthcare hub of the Sultanate, Muscat also accounted for a substantial portion of nationwide surgical operations. Across Oman, the Ministry of Health conducted many surgeries, with a large share performed in Muscat facilities due to their advanced capabilities and referral status. This procedural intensity naturally drives higher per-patient usage of medical consumables, reinforcing Muscat’s dominance in the market.

Moreover, ongoing accreditation initiatives for Muscat-based health institutions aim to align service quality with international standards, further institutionalizing processes that require standardized disposable consumables for infection control and patient safety. Muscat’s unique blend of treatment volume, infrastructure investment, and service quality commitments underscores why it remains the dominant region for medical consumables in Oman.

Gain a Competitive Edge with Our Oman Medical Consumables Market Report:

• The Oman Medical Consumables Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• The Oman Medical Consumables Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.